What specific coverage do the Cephamycins provide more of?

Cephamycins are a subclass of cephalosporins that have enhanced activity against anaerobic bacteria compared to other beta-lactam antibiotics. This specific coverage makes them particularly effective in treating infections where anaerobic organisms are implicated, such as in intra-abdominal infections or certain types of pneumonia.

While some other cephalosporins may have limited or no activity against anaerobes, cephamycins possess a unique structure that allows them to be more effective against these types of bacteria. They are capable of disrupting the cell wall synthesis of anaerobes, facilitating their elimination from the body. This characteristic is especially important in clinical settings where anaerobic infections are a concern, thus allowing for effective treatment options.

The other options do not fully capture the specific enhanced coverage that defines the cephamycins, as their primary strength lies in dealing with anaerobic pathogens.